越南肠易激综合征的患病率、临床特征及管理：一项范围综述
Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review.
作者信息
Quach Duc Trong, Vu Khoa Tien, Vu Khien Van
机构信息
Department of Internal Medicine University of Medicine and Pharmacy at Hochiminh City Ho Chi Minh City Vietnam.
Department of Gastroenterology Nhan Dan Gia Dinh Hospital Ho Chi Minh City Vietnam.
出版信息
JGH Open. 2021 Jul 21;5(11):1227-1235. doi: 10.1002/jgh3.12616. eCollection 2021 Nov.
Abstract
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders worldwide. Its prevalence varies significantly from country to country, largely due to heterogeneity in the available data. Recent studies show that the prevalence of IBS in Asia is on the rise. However, there are very limited data regarding its prevalence in the Vietnamese population. This review aims to offer an overview of the prevalence and clinical characteristics of IBS in the Vietnamese population; and to discuss the current management of IBS in Vietnam-taking into account the available medical resources and the local spectrum of lower gastrointestinal disorders that may mimic IBS.
摘要
肠易激综合征（IBS）是全球最常见的胃肠道疾病之一。其患病率在不同国家之间存在显著差异，这在很大程度上是由于现有数据的异质性所致。最近的研究表明，亚洲IBS的患病率正在上升。然而，关于越南人群中IBS患病率的数据非常有限。本综述旨在概述越南人群中IBS的患病率和临床特征；并结合现有的医疗资源以及可能模仿IBS的下消化道疾病的当地情况，讨论越南目前对IBS的管理。
相似文献
1
Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review.越南肠易激综合征的患病率、临床特征及管理：一项范围综述
JGH Open. 2021 Jul 21;5(11):1227-1235. doi: 10.1002/jgh3.12616. eCollection 2021 Nov.
2
The current prevalence of irritable bowel syndrome in Asia.亚洲目前肠易激综合征的流行情况。
J Neurogastroenterol Motil. 2010 Oct;16(4):389-400. doi: 10.5056/jnm.2010.16.4.389. Epub 2010 Oct 30.
3
Prevalence of irritable bowel syndrome and other functional gastrointestinal disorders in Uruguay.乌拉圭肠易激综合征和其他功能性胃肠疾病的流行情况。
Rev Gastroenterol Mex (Engl Ed). 2024 Apr-Jun;89(2):258-264. doi: 10.1016/j.rgmxen.2023.06.005. Epub 2024 Apr 20.
4
Endometriosis and irritable bowel syndrome: similarities and differences in the spectrum of comorbidities.子宫内膜异位症和肠易激综合征：共病谱中的相似性和差异性。
Hum Reprod. 2022 Aug 25;37(9):2186-2196. doi: 10.1093/humrep/deac140.
5
Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.印度、孟加拉国和马来西亚肠易激综合征的流行病学和临床观点：综述。
World J Gastroenterol. 2017 Oct 7;23(37):6788-6801. doi: 10.3748/wjg.v23.i37.6788.
6
Anxiety and Depression Disorders in Vietnamese Patients With Irritable Bowel Syndrome: A Cross-Sectional Clinic-Based Study.越南肠易激综合征患者的焦虑和抑郁障碍：一项基于门诊的横断面研究。
JGH Open. 2025 Feb 13;9(2):e70116. doi: 10.1002/jgh3.70116. eCollection 2025 Feb.
7
[The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile].[智利圣地亚哥购物中心访客人群中肠易激综合征症状的患病率]
Rev Gastroenterol Mex. 2013 Oct-Dec;78(4):203-10. doi: 10.1016/j.rgmx.2013.07.004. Epub 2013 Nov 27.
8
Epidemiology of irritable bowel syndrome in the former communist countries from Eastern Europe: a systematic review.东欧前共产主义国家肠易激综合征的流行病学：一项系统综述。
Clujul Med. 2015;88(2):146-51. doi: 10.15386/cjmed-449. Epub 2015 Apr 15.
9
Irritable bowel syndrome: a clinical review.肠易激综合征：临床综述
World J Gastroenterol. 2014 Sep 14;20(34):12144-60. doi: 10.3748/wjg.v20.i34.12144.
10
Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.阿片受体调节剂治疗肠易激综合征患者的疗效：系统评价和荟萃分析。
Medicine (Baltimore). 2021 Jan 29;100(4):e24361. doi: 10.1097/MD.0000000000024361.
引用本文的文献
1
Anxiety and Depression Disorders in Vietnamese Patients With Irritable Bowel Syndrome: A Cross-Sectional Clinic-Based Study.越南肠易激综合征患者的焦虑和抑郁障碍：一项基于门诊的横断面研究。
JGH Open. 2025 Feb 13;9(2):e70116. doi: 10.1002/jgh3.70116. eCollection 2025 Feb.
2
Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.钙卫蛋白、白细胞介素-6 和 C 反应蛋白在鉴别炎症性肠病与腹泻型肠易激综合征中的作用。
Med Arch. 2024;78(2):105-111. doi: 10.5455/medarh.2024.78.105-111.
3
The challenges of implementing evidence-based therapy for irritable bowel syndrome in Asia.在亚洲实施肠易激综合征循证治疗面临的挑战。
JGH Open. 2021 Nov 16;5(11):1225-1226. doi: 10.1002/jgh3.12665. eCollection 2021 Nov.
本文引用的文献
1
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics.世界胃肠病学组织全球指南：益生菌与益生元
J Clin Gastroenterol. 2024 Jul 1;58(6):533-553. doi: 10.1097/MCG.0000000000002002.
2
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.英国胃肠病学会关于肠易激综合征管理的指南。
Gut. 2021 Jul;70(7):1214-1240. doi: 10.1136/gutjnl-2021-324598. Epub 2021 Apr 26.
3
The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.根据罗马 III 与罗马 IV 标准，功能性胃肠疾病的流行病学和生活质量：初级保健中的横断面研究。
J Dig Dis. 2021 Mar;22(3):159-166. doi: 10.1111/1751-2980.12975.
4
ACG Clinical Guideline: Management of Irritable Bowel Syndrome.ACG 临床指南：肠易激综合征的管理。
Am J Gastroenterol. 2021 Jan 1;116(1):17-44. doi: 10.14309/ajg.0000000000001036.
5
Irritable Bowel Syndrome: Straightening the road from the Rome criteria.肠易激综合征：从罗马标准中找到出路。
Neurogastroenterol Motil. 2020 Nov;32(11):e13957. doi: 10.1111/nmo.13957. Epub 2020 Aug 17.
6
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.根据罗马 III 或 IV 标准，全球肠易激综合征的患病率：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. doi: 10.1016/S2468-1253(20)30217-X. Epub 2020 Jul 20.
7
Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.益生菌在肠易激综合征中的疗效与安全性：一项系统评价和荟萃分析
Front Pharmacol. 2020 Apr 3;11:332. doi: 10.3389/fphar.2020.00332. eCollection 2020.
8
Global burden of irritable bowel syndrome: trends, predictions and risk factors.全球肠易激综合征负担：趋势、预测和危险因素。
Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):473-486. doi: 10.1038/s41575-020-0286-8. Epub 2020 Apr 15.
9
Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis.心理疗法治疗肠易激综合征的疗效：系统评价和网络荟萃分析。
Gut. 2020 Aug;69(8):1441-1451. doi: 10.1136/gutjnl-2020-321191. Epub 2020 Apr 10.
10
Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.可溶性纤维、抗痉挛药物和肠道-脑神经调节剂在肠易激综合征中的疗效：系统评价和网络荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):117-131. doi: 10.1016/S2468-1253(19)30324-3. Epub 2019 Dec 16.
Zotero 插件